SCHEMBL845279

SCHEMBL845279

COc1ccccc1CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
MAPK1 P28482 2/20 0.52
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
NPSR1 Q6W5P4 1/20 0.50
HTT P42858 1/20 0.49
APP P05067 2/20 0.47
ATM Q13315 1/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
EP300 Q09472 1/20 0.47
CREBBP Q92793 1/20 0.47
ITGB1 P05556 1/20 0.46
ITGA4 P13612 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845618 0.95 MAPK1 (0.56) ALDH1A1MAPK1CYP2C9CYP2C19MEN1
SCHEMBL13272444 0.89 ALDH1A1 (0.56) ALDH1A1MAPK1CYP2C9CYP2C19HTT
SCHEMBL845226 0.89 ALDH1A1 (0.56) ALDH1A1MAPK1CYP2C9CYP2C19HTT
SCHEMBL1030175 0.89 ALDH1A1 (0.56) ALDH1A1MAPK1CYP2C9CYP2C19HTT
SCHEMBL845205 0.89 ALDH1A1 (0.56) ALDH1A1MAPK1CYP2C9CYP2C19HTT
SCHEMBL845111 0.89 ALDH1A1 (0.56) ALDH1A1MAPK1CYP2C9CYP2C19HTT
SCHEMBL15116912 0.89 ALDH1A1 (0.56) ALDH1A1MAPK1CYP2C9CYP2C19HTT
SCHEMBL845353 0.88 KDM4E (0.52) ALDH1A1MAPK1CYP2C9CYP2C19NPSR1
SCHEMBL845567 0.87 ALDH1A1 (0.50) ALDH1A1MAPK1CYP2C9CYP2C19NPSR1
SCHEMBL845305 0.86 GAA (0.58) ALDH1A1MAPK1CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed